Immunohistochemistry Test Detects ROS1 Protein in Cancer
The biomarker may provide a cost-effective and efficient means to identify elevated ROS1 protein expression in cancer.
Read More
Search Results for: lung cancer
Genetic Cancer Test Granted FDA Breakthrough Device Designation
The designation’s accelerated regulatory review is intended to expedite use of the diagnostic in pharmaceutical trials.
Read MoreLab Readiness Program Speeds Cancer Patient Access to Combination Products
LabCorp joins Qiagen ‘Day-One’ lab readiness program designed to deliver precision medicine to patients faster.
Read MoreResearch Collaboration Aims to Improve Use of PCR Technology to Detect Cancer Recurrence
Patient-specific assays detect low-volume minimal residual disease at high levels of sensitivity and characterize the landscape of relapsing lung cancer.
Read More
FDA Approves Companion Diagnostic for Triple-Negative Breast Cancer
The assay is the first companion diagnostic approved for identifying triple-negative breast cancer patients who are eligible for PD-L1 immunotherapy.
Read More